-
1
المؤلفون: Stefan Schreiber, Richard N. Fedorak, Mary E. Keir, Daan W. Hommes, Sharon O'Byrne, Meina Tang, Daniel C. Baumgart, Diana Luca, Paul Rutgeerts, John C. Mansfield, Brian Bressler, Andreas Sturm, Dimitri Danilenko, Marna Williams, Xiaohui Wei, Jackson G. Egen, Jennifer Visich
المصدر: Gut, vol 62, iss 8
مصطلحات موضوعية: Male, Ulcerative, Gastroenterology, rhuMAb 7, Severity of Illness Index, immunology, Monoclonal, Medicine, Etrolizumab, genetics, Stage (cooking), IBD models, Infusions, Intravenous, Humanized, Subcutaneous, apoptosis, Antibodies, Monoclonal, Crohns disease, Middle Aged, Colitis, Ulcerative colitis, inflammatory bowel disorders, Phase i study, Crohn's disease, Treatment Outcome, arthritis, 6.1 Pharmaceuticals, Cohort, cell cycle, Female, Drug, IBD–genetics, Intravenous, pharmacokinetics, signal transduction, Biotechnology, safety, Adult, medicine.medical_specialty, Infusions, Adolescent, Injections, Subcutaneous, Clinical Trials and Supportive Activities, IBD, Clinical Sciences, autoimmune disease, Placebo, Antibodies, Monoclonal, Humanized, Antibodies, Injections, Dose-Response Relationship, Paediatrics and Reproductive Medicine, Young Adult, Pharmacokinetics, Double-Blind Method, Gastrointestinal Agents, Clinical Research, Internal medicine, Humans, dendritic cells, Adverse effect, ulcerative colitis, Aged, Gastroenterology & Hepatology, Dose-Response Relationship, Drug, business.industry, Inflammatory Bowel Disease, IBD-genetics, Evaluation of treatments and therapeutic interventions, rhuMAb β7, medicine.disease, drug development, cytokines, Surgery, antibody targeted therapy, IBD clinical, IBD basic research, integrins, Colitis, Ulcerative, Digestive Diseases, business
وصف الملف: application/pdf